The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
Human Molecular Genetics (Impact Factor: 6.39). 11/2005; 14(19):2829-37. DOI: 10.1093/hmg/ddi315
Source: PubMed


Stroke is the leading cause of severe disability and the third leading cause of death, accounting for one of every 15 deaths in the USA. We investigated the association of polymorphisms in the soluble epoxide hydrolase gene (EPHX2) with incident ischemic stroke in African-Americans and Whites. Twelve single nucleotide polymorphisms (SNPs) spanning EPHX2 were genotyped in a case-cohort sample of 1336 participants from the Atherosclerosis Risk in Communities (ARIC) study. In each racial group, Cox proportional hazard models were constructed to assess the relationship between incident ischemic stroke and EPHX2 polymorphisms. A score test method was used to investigate the association of common haplotypes of the gene with risk of ischemic stroke. In African-Americans, two common EPHX2 haplotypes with significant and opposing relationships to ischemic stroke risk were identified. In Whites, two common haplotypes showed suggestive indication of an association with ischemic stroke risk but, as in African-Americans, these relationships were in opposite direction. These findings suggest that multiple variants exist within or near the EPHX2 gene, with greatly contrasting relationships to ischemic stroke incidence; some associated with a higher incidence and others with a lower incidence.

Download full-text


Available from: Molly Bray,
  • Source
    • "Three SNPs (SNP 9, SNP 14 and SNP 23) of EPHX2 showed a significant association with an increased risk of ischemic stroke REVIEW in European patients in the ARIC study (Gschwendtner et al. 2008). Interestingly, two common EPHX2 haplotypes showed apparent and opposing relationships of an association with ischemic stroke risk both in African-Americans and Whites, with one haplotype showed a significantly lower risk of ischemic stroke and another showed higher (Fornage et al. 2005). Taken together, a number of genetic studies have suggested that EPHX2 could be a potential candidate gene for cardiovascular diseases. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Epoxyeicosatrienoic acids (EETs) are cytochrome P450 (CYP450) products of arachidonic acid and EETs are endogenous lipid mediators synthesized by the vascular endothelium which perform important biological functions, including vasodilation, anti-inflammation, antimigratory, and cellular signaling regulations. However, EETs are rapidly degraded by soluble epoxide hydrolase (sEH) to the corresponding diols: dihydroxyeicosatrienoic acids (DHETs), which have little active in causing vasorelaxation. A number of studies have supported that the inhibition of sEH (sEHIs) had cardiovascular protective effects in hypertension, cardiac hypertrophy, atherosclerosis, ischemia-reperfusion injury, and ischemic stroke. Moreover, sEHIs could slow the progression of inflammation, protect end-organ damage and prevent ischemic events, also, attenuate endothelial dysfunction, suggesting that the pharmacological blockade of sEH might provide a broad and novel avenue for the treatment of many cardiovascular diseases.
    Pharmazie 03/2011; 66(3):153-7. DOI:10.1692/ph.2011.0709 · 1.05 Impact Factor
  • Source
    • "It was shown that the association of polymorphisms within the EPHX2 gene with cardiovascular risks strongly depends on the ethnical background of the analysed populations [26,35]. Indeed, the reported association could only be observed in Caucasian CHD cases and not in African-Americans. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether the EPHX2 K55R polymorphism, previously linked to significantly higher risk for coronary heart disease (CHD), was associated with the occurrence of restenosis after PCI. The association with incident CHD should have been confirmed and a potential correlation of the EPHX2 K55R variant to an increased risk of hypertension was analysed. An overall cohort of 706 patients was studied: This cohort comprised of 435 CHD patients who had undergone successful PCI. Follow-up coronary angiography in all patients was performed 6 months after intervention. Another 271 patients in whom CHD had been excluded by coronary angiography served as controls. From each patient EDTA-blood was drawn at the baseline ward round. Genomic DNA was extracted from these samples and genotyping was performed by real-time PCR and subsequent melting curve analysis. In CHD patients 6 month follow-up coronary angiography revealed a restenosis rate of 29.4%, classified as late lumen loss as well as lumen re-narrowing >or= 50%.Statistical analysis showed an equal genotype distribution in restenosis patients and non-restenosis patients (A/A 82.0% and A/G + G/G 18.0% versus A/A 82.1% and A/G + G/G 17.9%). Moreover, neither a significant difference in the genotype distribution of CHD patients and controls nor an association with increased risk of hypertension was found. The results of the present study indicate that the EPHX2 K55R polymorphism is not associated with restenosis after PCI, with incidence of CHD, or with an increased risk of hypertension and therefore, can not serve as a predictor for risk of CHD or restenosis after PCI.
    BMC Cardiovascular Disorders 10/2009; 9(1):48. DOI:10.1186/1471-2261-9-48 · 1.88 Impact Factor
  • Source
    • "Nevertheless, future studies are needed to confirm the effects of EPHX2 SNPs on cell death in human neurons. Finally, a recent case-cohort study examining the relationship between EPHX2 polymorphisms and coronary heart disease reported that the frequencies of some of the EPHX2 variants examined in our study, for example, the Cys154Try variant and the double mutant, are rare in the human population, whereas other more common variants, such as R402Ins/Del and E470G, were not investigated in our study (Fornage et al., 2005; Lee et al., 2006). "

Show more